Disc Medicine (IRON) Interest Coverage Ratio (2020 - 2026)
Disc Medicine (IRON) reported Interest Coverage Ratio of 82.37 for Q1 2026, down 84.97% year-over-year from 548.22 in Q1 2025, and down 8.61% quarter-over-quarter from 75.84 in Q4 2025.
Disc Medicine (IRON) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 6 years of Interest Coverage Ratio data on file, last reported at 82.37 in Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 82.37, down 84.97% year-over-year; the trailing twelve-month figure through Mar 2026 was 74.73 (up 20.57% YoY), and the FY2025 annual result was 65.43, up 71.15% from the prior year.
- Interest Coverage Ratio declined to 82.37 in Q1 2026 per IRON's latest filing, from 75.84 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 44.53 in Q1 2025 and troughed at 250.31 in Q2 2022.
- A 4-year average of 100.71 and a median of 74.83 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio sank 1591.21% in 2022, then fell 25.56% in 2025.
- A 4-year view of Interest Coverage Ratio shows it stood at 250.31 in 2022, then soared by 75.87% to 60.4 in 2024, then decreased by 25.56% to 75.84 in 2025, then retreated by 8.61% to 82.37 in 2026.
- Business Quant data shows IRON's Interest Coverage Ratio at 82.37 in Q1 2026, 75.84 in Q4 2025, and 73.82 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Disc Medicine | 2.73 Bn | 2.00 Bn | - | -82.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82.37 |
| Dec 31, 2025 | -75.84 |
| Sep 30, 2025 | -73.82 |
| Jun 30, 2025 | -67.48 |
| Mar 31, 2025 | -44.53 |
| Dec 31, 2024 | -60.40 |
| Jun 30, 2022 | -250.31 |
| Mar 31, 2022 | -150.91 |
| Dec 31, 2021 | 9.48 |
| Sep 30, 2021 | -9,225.00 |
| Jun 30, 2021 | -134.88 |
| Mar 31, 2021 | -8.92 |
| Dec 31, 2020 | -0.18 |
| Sep 30, 2020 | -3.88 |
| Jun 30, 2020 | -62.30 |
| Mar 31, 2020 | -62.95 |